[SCHEDULE 13G] Esperion Therapeutics, Inc. SEC Filing
Two Seas Capital LP, Two Seas Capital GP LLC and Sina Toussi report beneficial ownership of 9,954,975 shares of Esperion Therapeutics common stock, representing 5.0% of the class based on 198,199,462 shares outstanding. The shares are held by Two Seas Global (Master) Fund LP, for which Two Seas Capital acts as investment adviser and has sole voting and dispositive power; TSC GP and Mr. Toussi are identified through their general partner and managing member roles.
The filing states the position is held in the ordinary course of business and not to change or influence control of the issuer. The disclosure quantifies position size and control over voting and disposition rights without indicating an intent to seek corporate control.
Two Seas Capital LP, Two Seas Capital GP LLC e Sina Toussi dichiarano la titolarit脿 effettiva di 9,954,975 azioni ordinarie di Esperion Therapeutics, pari al 5,0% della classe su un totale di 198,199,462 azioni in circolazione. Le azioni sono detenute da Two Seas Global (Master) Fund LP, per la quale Two Seas Capital agisce come consulente per gli investimenti e detiene il potere esclusivo di voto e di disposizione; TSC GP e il sig. Toussi sono identificati tramite i loro ruoli di general partner e managing member.
La comunicazione dichiara che la posizione 猫 detenuta nell'ordinaria attivit脿 d'impresa e non per modificare o influenzare il controllo dell'emittente. La disclosure quantifica l'entit脿 della posizione e il controllo sui diritti di voto e di disposizione senza indicare l'intenzione di cercare il controllo societario.
Two Seas Capital LP, Two Seas Capital GP LLC y Sina Toussi informan la titularidad beneficiaria de 9,954,975 acciones ordinarias de Esperion Therapeutics, que representan el 5,0% de la clase sobre 198,199,462 acciones en circulaci贸n. Las acciones son propiedad de Two Seas Global (Master) Fund LP, para el cual Two Seas Capital act煤a como asesor de inversiones y tiene el poder exclusivo de voto y de disposici贸n; TSC GP y el Sr. Toussi se identifican a trav茅s de sus roles de general partner y managing member.
La presentaci贸n indica que la posici贸n se mantiene en el curso ordinario del negocio y no para cambiar o influir en el control del emisor. La divulgaci贸n cuantifica el tama帽o de la posici贸n y el control sobre los derechos de voto y disposici贸n sin indicar la intenci贸n de buscar el control corporativo.
Two Seas Capital LP, Two Seas Capital GP LLC 氚� Sina Toussi電� Esperion Therapeutics鞚� 氤错喌欤� 9,954,975欤检棎 雽�頃� 鞁れ鞝� 靻岇湢甓岇潉 氤搓碃頄堨溂氅�, 鞚措姅 齑� 198,199,462欤� 欷� 頃措嫻 膦呺鞚� 5.0%鞐� 頃措嫻頃╇媹雼�. 頃措嫻 欤检嫕鞚� Two Seas Global (Master) Fund LP臧� 氤挫湢頃橁碃 鞛堨溂氅�, Two Seas Capital鞚� 頃措嫻 韼�霌滌潣 韴瀽鞛愲靷靹� 雼弲 鞚橁舶甓� 氚� 觳橂秳甓岇潉 氤挫湢頃╇媹雼�; TSC GP鞕� Mr. Toussi電� 攴鸽摛鞚� 鞚茧皹 韺岉姼雱�(general partner) 氚� 毵る媹歆� 氅る矂(managing member) 鞐暊鞚� 韱淀暣 鞁濍硠霅╇媹雼�.
鞁犼碃靹滊姅 鞚� 歆�攵勳澊 韱奠儊鞝侅澑 鞓侅梾 瓿检爼鞐愳劀 氤挫湢霅� 瓴冹澊氅� 氚滍枆鞚胳潣 歆�氚瓣秾鞚� 氤�瓴巾晿瓯半倶 鞓來枼霠レ潉 頄夓偓頃橁赴 鞙勴暅 瓴冹澊 鞎勲嫎鞚� 氇呾嫓頃╇媹雼�. 瓿奠嫓電� 歆�攵� 攴滊鞕� 鞚橁舶甓� 氚� 觳橂秳甓岇棎 雽�頃� 韱奠牅霠レ潉 靾橂焿頇旐晿霅�, 旮办梾 歆�氚瓣秾鞚� 於旉惮頃橂牑電� 鞚橂弰電� 雮橅儉雮挫 鞎婌姷雼堧嫟.
Two Seas Capital LP, Two Seas Capital GP LLC et Sina Toussi d茅clarent la propri茅t茅 b茅n茅ficiaire de 9,954,975 actions ordinaires d'Esperion Therapeutics, soit 5,0% de la cat茅gorie sur un total de 198,199,462 actions en circulation. Les actions sont d茅tenues par Two Seas Global (Master) Fund LP, pour lequel Two Seas Capital agit en tant que conseiller en investissement et d茅tient le pouvoir exclusif de vote et de disposition ; TSC GP et M. Toussi sont identifi茅s via leurs fonctions de general partner et de managing member.
Le d茅p么t indique que la position est d茅tenue dans le cours normal des affaires et n'a pas pour objet de modifier ou d'influencer le contr么le de l'茅metteur. La divulgation quantifie la taille de la position et le contr么le sur les droits de vote et de disposition sans indiquer l'intention de chercher 脿 prendre le contr么le de la soci茅t茅.
Two Seas Capital LP, Two Seas Capital GP LLC und Sina Toussi melden die wirtschaftliche Eigent眉merschaft an 9,954,975 Aktien der Stammaktien von Esperion Therapeutics, was 5,0% der Klasse auf Basis von 198,199,462 ausstehenden Aktien entspricht. Die Aktien werden von Two Seas Global (Master) Fund LP gehalten, f眉r die Two Seas Capital als Anlageberater fungiert und alleinige Stimm- und Verf眉gungsbefugnis besitzt; TSC GP und Herr Toussi sind 眉ber ihre Rollen als General Partner und Managing Member identifiziert.
Die Meldung besagt, dass die Position im normalen Rahmen der Gesch盲ftst盲tigkeit gehalten wird und nicht dazu dient, die Kontrolle 眉ber den Emittenten zu ver盲ndern oder zu beeinflussen. Die Offenlegung beziffert die Positionsgr枚脽e und die Kontrolle 眉ber Stimm- und Verf眉gungsrechte, ohne eine Absicht zur Erlangung der Unternehmenskontrolle anzudeuten.
- Beneficial ownership of 9,954,975 shares (~5.0% of outstanding common stock)
- Reporting Persons have sole voting and sole dispositive power over the shares
- Filing states holdings are in the ordinary course of business and not to change or influence control
- Ownership held through an investment vehicle (Two Seas Global (Master) Fund LP) with clear adviser structure
- None.
Insights
TL;DR: A 5.0% stake (9.95M shares) is disclosed with sole voting and dispositive power; this is a notable but non-controlling institutional position.
The filing shows Two Seas-affiliated entities and Sina Toussi collectively beneficially own 9,954,975 shares, calculated against 198,199,462 shares outstanding. The disclosure clarifies sole voting and dispositive authority over the position and includes a certification that the holdings are in the ordinary course of business, not intended to effect control. For investors, this documents a sizeable passive stake by an investment adviser rather than an overt control attempt.
TL;DR: Reporting persons hold sole voting/dispositive power over a 5% block but certify no intent to change issuer control.
The schedule identifies ownership through Two Seas Global (Master) Fund LP with Two Seas Capital as investment adviser, TSC GP as general partner, and Sina Toussi in managerial roles, each shown with sole voting and dispositive power for 9,954,975 shares. The certification in Item 10 explicitly states the shares were not acquired to influence control, which limits immediate governance implications, though any future change in intent would require updated disclosures.
Two Seas Capital LP, Two Seas Capital GP LLC e Sina Toussi dichiarano la titolarit脿 effettiva di 9,954,975 azioni ordinarie di Esperion Therapeutics, pari al 5,0% della classe su un totale di 198,199,462 azioni in circolazione. Le azioni sono detenute da Two Seas Global (Master) Fund LP, per la quale Two Seas Capital agisce come consulente per gli investimenti e detiene il potere esclusivo di voto e di disposizione; TSC GP e il sig. Toussi sono identificati tramite i loro ruoli di general partner e managing member.
La comunicazione dichiara che la posizione 猫 detenuta nell'ordinaria attivit脿 d'impresa e non per modificare o influenzare il controllo dell'emittente. La disclosure quantifica l'entit脿 della posizione e il controllo sui diritti di voto e di disposizione senza indicare l'intenzione di cercare il controllo societario.
Two Seas Capital LP, Two Seas Capital GP LLC y Sina Toussi informan la titularidad beneficiaria de 9,954,975 acciones ordinarias de Esperion Therapeutics, que representan el 5,0% de la clase sobre 198,199,462 acciones en circulaci贸n. Las acciones son propiedad de Two Seas Global (Master) Fund LP, para el cual Two Seas Capital act煤a como asesor de inversiones y tiene el poder exclusivo de voto y de disposici贸n; TSC GP y el Sr. Toussi se identifican a trav茅s de sus roles de general partner y managing member.
La presentaci贸n indica que la posici贸n se mantiene en el curso ordinario del negocio y no para cambiar o influir en el control del emisor. La divulgaci贸n cuantifica el tama帽o de la posici贸n y el control sobre los derechos de voto y disposici贸n sin indicar la intenci贸n de buscar el control corporativo.
Two Seas Capital LP, Two Seas Capital GP LLC 氚� Sina Toussi電� Esperion Therapeutics鞚� 氤错喌欤� 9,954,975欤检棎 雽�頃� 鞁れ鞝� 靻岇湢甓岇潉 氤搓碃頄堨溂氅�, 鞚措姅 齑� 198,199,462欤� 欷� 頃措嫻 膦呺鞚� 5.0%鞐� 頃措嫻頃╇媹雼�. 頃措嫻 欤检嫕鞚� Two Seas Global (Master) Fund LP臧� 氤挫湢頃橁碃 鞛堨溂氅�, Two Seas Capital鞚� 頃措嫻 韼�霌滌潣 韴瀽鞛愲靷靹� 雼弲 鞚橁舶甓� 氚� 觳橂秳甓岇潉 氤挫湢頃╇媹雼�; TSC GP鞕� Mr. Toussi電� 攴鸽摛鞚� 鞚茧皹 韺岉姼雱�(general partner) 氚� 毵る媹歆� 氅る矂(managing member) 鞐暊鞚� 韱淀暣 鞁濍硠霅╇媹雼�.
鞁犼碃靹滊姅 鞚� 歆�攵勳澊 韱奠儊鞝侅澑 鞓侅梾 瓿检爼鞐愳劀 氤挫湢霅� 瓴冹澊氅� 氚滍枆鞚胳潣 歆�氚瓣秾鞚� 氤�瓴巾晿瓯半倶 鞓來枼霠レ潉 頄夓偓頃橁赴 鞙勴暅 瓴冹澊 鞎勲嫎鞚� 氇呾嫓頃╇媹雼�. 瓿奠嫓電� 歆�攵� 攴滊鞕� 鞚橁舶甓� 氚� 觳橂秳甓岇棎 雽�頃� 韱奠牅霠レ潉 靾橂焿頇旐晿霅�, 旮办梾 歆�氚瓣秾鞚� 於旉惮頃橂牑電� 鞚橂弰電� 雮橅儉雮挫 鞎婌姷雼堧嫟.
Two Seas Capital LP, Two Seas Capital GP LLC et Sina Toussi d茅clarent la propri茅t茅 b茅n茅ficiaire de 9,954,975 actions ordinaires d'Esperion Therapeutics, soit 5,0% de la cat茅gorie sur un total de 198,199,462 actions en circulation. Les actions sont d茅tenues par Two Seas Global (Master) Fund LP, pour lequel Two Seas Capital agit en tant que conseiller en investissement et d茅tient le pouvoir exclusif de vote et de disposition ; TSC GP et M. Toussi sont identifi茅s via leurs fonctions de general partner et de managing member.
Le d茅p么t indique que la position est d茅tenue dans le cours normal des affaires et n'a pas pour objet de modifier ou d'influencer le contr么le de l'茅metteur. La divulgation quantifie la taille de la position et le contr么le sur les droits de vote et de disposition sans indiquer l'intention de chercher 脿 prendre le contr么le de la soci茅t茅.
Two Seas Capital LP, Two Seas Capital GP LLC und Sina Toussi melden die wirtschaftliche Eigent眉merschaft an 9,954,975 Aktien der Stammaktien von Esperion Therapeutics, was 5,0% der Klasse auf Basis von 198,199,462 ausstehenden Aktien entspricht. Die Aktien werden von Two Seas Global (Master) Fund LP gehalten, f眉r die Two Seas Capital als Anlageberater fungiert und alleinige Stimm- und Verf眉gungsbefugnis besitzt; TSC GP und Herr Toussi sind 眉ber ihre Rollen als General Partner und Managing Member identifiziert.
Die Meldung besagt, dass die Position im normalen Rahmen der Gesch盲ftst盲tigkeit gehalten wird und nicht dazu dient, die Kontrolle 眉ber den Emittenten zu ver盲ndern oder zu beeinflussen. Die Offenlegung beziffert die Positionsgr枚脽e und die Kontrolle 眉ber Stimm- und Verf眉gungsrechte, ohne eine Absicht zur Erlangung der Unternehmenskontrolle anzudeuten.
FAQ
How many ESPR shares do Two Seas report owning?
What percentage of Esperion (ESPR) does the position represent?
Who are the reporting persons on the Schedule 13G for ESPR?
Does Two Seas have voting or dispositive power over the ESPR shares?
Is the stake reported as intended to influence control of Esperion?
